Skip to main content

Table 4 Associations between significant neoplasia and bleeding observations in patients with bleeding

From: Findings in young adults at colonoscopy from a hospital service database audit

   Age <50 % P-value Age ≥50 % P-value All % P-value
   n=    n=    n=   
Totals Patients with bleeding 137    561    698   
Any bleeding With CPL/CRC 10 7.3 0.18 101 18.0 0.03 111 15.9 0.005
With SSA/P 5 3.6 0.2 17 3.0 0.53 22 3.2 0.99
With AA 4 2.9 0.54 65 11.6 0.03 69 9.9 0.008
Totals Patients with overt bleeding n = 108    n = 240    n = 348   
Overt bleeding With CPL/CRC 8 7.4 0.17 40 16.7 0.31 48 13.8 0.34
With SSA/P 4 3.7 0.21 8 3.3 0.56 12 3.4 0.42
With AA 4 3.7 0.21 23 9.6 0.49 27 7.8 0.52
Totals Patients with occult bleeding n = 29    n = 321    n = 350   
Occult bleeding With CPL/CRC 2 6.9 0.45 61 19.0 0.03 63 18.0 0.002
With SSA/P 1 3.4 0.5 9 2.8 0.31 10 2.9 0.44
With AA 0 0.0 0.5 42 13.1 0.009 42 12.0 0.001
  1. CPL/CRC CRC precursor lesions and/or CRC, SSA/P sessile serrated polyp, AA advanced conventional adenoma (≥10 mm or high-grade dysplasia or villous histology)
  2. Significant p-values are shown in italics